NeoGenomics Inc (NEO)

Exchange
NASDAQ
Symbol
NEO
Sector
Trade & Services
Industry
Services-testing Laboratories
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. The company is headquartered in Fort Myers, Florida.
Country
USA

Stock price

At close: December 20, 2024

  • Open
    16.19
  • High
    16.60
  • Low
    16.19
  • Close
    16.41
  • Volume
    3,306,030

Financial ratios

Dec 31, 2023

Activity ratios
Inventory turnover
29.32
Receivables turnover
4.58
Payables turnover
34.83
Working capital turnover
1.20
Days of inventory on hand (DOH)
12.45
Days of sales outstanding (DSO)
79.61
Number of days of payables
10.48
Fixed asset turnover
6.54
Total asset turnover
0.36
 Liquidity ratios
Current ratio
6.20
Quick ratio
5.67
Cash ratio
4.31
Cash conversion cycle
81.58
 Solvency ratios
Debt-to-assets ratio
0.32
Debt-to-capital ratio
0.36
Debt-to-equity ratio
0.57
Financial leverage ratio
1.79
Interest coverage
-13.06
 Profitability ratios
Gross profit margin
40.66%
Operating profit margin
-17.91%
Pretax margin
-16.14%
Net profit margin
-14.62%
Operating return on assets (Operating ROA)
-6.41%
Return on assets (ROA)
-5.23%
Return on total capital
-6.10%
Return on equity (ROE)
-9.34%